Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Authors
Keywords
-
Journal
BRAIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-05-03
DOI
10.1093/brain/awz134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted 5-HT1F Therapies for Migraine
- (2018) Marta Vila-Pueyo Neurotherapeutics
- Is selective 5-HT 1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
- (2018) Eloísa Rubio-Beltrán et al. PHARMACOLOGY & THERAPEUTICS
- Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects
- (2018) Ahmed N Mahmoud et al. BMJ Open
- Lasmiditan is an effective acute treatment for migraine
- (2018) Bernice Kuca et al. NEUROLOGY
- The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
- (2017) Bianca Raffaelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
- (2017) Richard B. Lipton et al. HEADACHE
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Simon I Hay et al. LANCET
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
- (2016) Dawn C. Buse et al. HEADACHE
- The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
- (2015) Michael J. Marmura et al. HEADACHE
- Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
- (2015) Chris Cameron et al. HEADACHE
- Trends in the Ambulatory Management of Headache: Analysis of NAMCS and NHAMCS Data 1999–2010
- (2015) John N. Mafi et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Triptan nonresponders: Do they exist and who are they?
- (2013) Michele Viana et al. CEPHALALGIA
- Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
- (2013) Richard B. Lipton et al. HEADACHE
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
- (2012) Markus Färkkilä et al. LANCET NEUROLOGY
- Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
- (2010) Michel D Ferrari et al. CEPHALALGIA
- Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) Questionnaire
- (2010) R.B. Lipton et al. HEADACHE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now